BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19144758)

  • 1. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.
    Ma D; Lim T; Xu J; Tang H; Wan Y; Zhao H; Hossain M; Maxwell PH; Maze M
    J Am Soc Nephrol; 2009 Apr; 20(4):713-20. PubMed ID: 19144758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.
    Hong YA; Jung SY; Yang KJ; Im DS; Jeong KH; Park CW; Hwang HS
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice.
    Jia P; Teng J; Zou J; Fang Y; Zhang X; Bosnjak ZJ; Liang M; Ding X
    Anesthesiology; 2013 Sep; 119(3):621-30. PubMed ID: 23681145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
    He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
    Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury.
    Kapitsinou PP; Sano H; Michael M; Kobayashi H; Davidoff O; Bian A; Yao B; Zhang MZ; Harris RC; Duffy KJ; Erickson-Miller CL; Sutton TA; Haase VH
    J Clin Invest; 2014 Jun; 124(6):2396-409. PubMed ID: 24789906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
    Imamura R; Moriyama T; Isaka Y; Namba Y; Ichimaru N; Takahara S; Okuyama A
    Transplantation; 2007 May; 83(10):1371-9. PubMed ID: 17519789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor-1alpha mediates protective effects of ischemic preconditioning on ECV-304 endothelial cells.
    Shi LB; Huang JH; Han BS
    World J Gastroenterol; 2007 Apr; 13(16):2369-73. PubMed ID: 17511040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent.
    Rao K; Sethi K; Ischia J; Gibson L; Galea L; Xiao L; Yim M; Chang M; Papa N; Bolton D; Shulkes A; Baldwin GS; Patel O
    PLoS One; 2017; 12(7):e0180028. PubMed ID: 28686686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury.
    Date T; Mochizuki S; Belanger AJ; Yamakawa M; Luo Z; Vincent KA; Cheng SH; Gregory RJ; Jiang C
    Am J Physiol Cell Physiol; 2005 Feb; 288(2):C314-20. PubMed ID: 15496478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning attenuates ischemia/reperfusion-induced kidney injury by activating autophagy via the SGK1 signaling pathway.
    Xie Y; Jiang D; Xiao J; Fu C; Zhang Z; Ye Z; Zhang X
    Cell Death Dis; 2018 Mar; 9(3):338. PubMed ID: 29497029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent exposure to xenon protects against gentamicin-induced nephrotoxicity.
    Jia P; Teng J; Zou J; Fang Y; Jiang S; Yu X; Kriegel AJ; Liang M; Ding X
    PLoS One; 2013; 8(5):e64329. PubMed ID: 23737979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenon Treatment Protects against Remote Lung Injury after Kidney Transplantation in Rats.
    Zhao H; Huang H; Ologunde R; Lloyd DG; Watts H; Vizcaychipi MP; Lian Q; George AJ; Ma D
    Anesthesiology; 2015 Jun; 122(6):1312-26. PubMed ID: 25856291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney.
    Kojima I; Tanaka T; Inagi R; Kato H; Yamashita T; Sakiyama A; Ohneda O; Takeda N; Sata M; Miyata T; Fujita T; Nangaku M
    J Am Soc Nephrol; 2007 Apr; 18(4):1218-26. PubMed ID: 17344427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenon Protects Against Septic Acute Kidney Injury via miR-21 Target Signaling Pathway.
    Jia P; Teng J; Zou J; Fang Y; Wu X; Liang M; Ding X
    Crit Care Med; 2015 Jul; 43(7):e250-9. PubMed ID: 25844699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient ureteral obstruction prevents against kidney ischemia/reperfusion injury via hypoxia-inducible factor (HIF)-2α activation.
    Zhang S; Han CH; Chen XS; Zhang M; Xu LM; Zhang JJ; Xia Q
    PLoS One; 2012; 7(1):e29876. PubMed ID: 22295069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflurane preconditioning increases survival of rat skin random-pattern flaps by induction of HIF-1α expression.
    Sun Y; Li QF; Zhang Y; Hu R; Jiang H
    Cell Physiol Biochem; 2013; 31(4-5):579-91. PubMed ID: 23635649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
    Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
    J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
    Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
    Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells.
    Rizvi M; Jawad N; Li Y; Vizcaychipi MP; Maze M; Ma D
    Exp Biol Med (Maywood); 2010 Jul; 235(7):886-91. PubMed ID: 20472713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.